Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL2020 in Neonatal Hypoxic Ischemic Encephalopathy Patients With Therapeutic Hypothermia
NCT04261335Phase 1Completed
- Sponsor
- Nagoya University
- Start
- Mar 2020
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in hypoxic-ischemic encephalopathy (HIE), sponsored by Nagoya University. Primary endpoint: Incidence of adverse events at 12 weeks. Started Mar 2020; status: completed.
02
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT04261335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04261335.